Premenstrual dysphoric disorder: Treatment with sertraline, neuropsychological effects, and flight status

Aviation Space and Environmental Medicine

Volumn 78, Issue 5 II, 2007, Pages

  Kratz, Kris ^a,c   Anderson, Sara ^a   Poppen, Bradley ^b  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

^b WOMACK ARMY MEDICAL CENTER   (United States)

^c SOTF   (United States)

Author keywords

Aviation performance; Menses; Neuropsychological assessment; Selective serotonin reuptake inhibitors

Indexed keywords

DOXYCYCLINE; NAPROXEN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AEROSPACE MEDICINE; AIRPLANE CREW; AIRPLANE PILOT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DATA ANALYSIS; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; MENSTRUATION; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PREMENSTRUAL DYSPHORIC DISORDER; STANDARDIZATION; THERAPY EFFECT;

ADULT; ANTIDEPRESSIVE AGENTS; AVIATION; FEMALE; HUMANS; MILITARY PERSONNEL; NEUROPSYCHOLOGICAL TESTS; PREMENSTRUAL SYNDROME; SERTRALINE;

EID: 34248181592     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. th ed., text revision. Washington, DC: American Psychiatric Association, Inc.; 2000.
2. Dell DL. Premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of another disorder. Clin Obstet Gynecol 2004; 47:568-75.
3. Ewing R, McCarthy D, Gronwall D, Wrightson P. Persisting effects of minor head injury observable during hypoxic stress. J Clin Neuropsychol 1980; 2:147-55.
4. Gordon HW, Leighty R. Importance of specialized cognitive function in the selection of military pilots. J Appl Psychol 1988; 73:38-45.
5. Halbreich U, Kahn LS. Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline. Expert Opin Pharmacother 2003; 4:2065-78.
6. Ireland RR. Pharmacologic considerations for serotonin reuptake inhibitor use by aviators. Aviat Space Environ Med 2002; 73: 421-9.
7. Johnson SR. Premenstrual syndrome, premenstrual dysphoric disorder and beyond: a clinical primer for practitioners. Obstet Gynecol 2004; 104:845-59.
8. Jones DR, Ireland RR. Aeromedical regulation of aviators using selective serotonin reuptake inhibitors for depressive disorders. Aviat Space Environ Med 2004; 75:461-70.
9. th ed. New York: Oxford University Press; 2004.
10. Man MS, MacMillan I, Scott J, Young AH. Mood, neuropsychological function and cognitions in premenstrual dysphoric disorder. Psychol Med 1999; 29:727-33.
11. Morgan M, Rapkin A. Cognitive flexibility, reaction time, and attention in women with premenstrual dysphoric disorder. J Gend Specif Med 2002; 5:28-36.
12. Morgan M, Rapkin AJ, D'Elia L, et al. Cognitive functioning in premenstrual syndrome. Obstet Gynecol 1996; 88:961-6.
13. Paul MA, Gray G, Lange M. The impact of sertraline on psychomotor performance. Aviat Space Environ Med 2002; 73:964-70.
14. Stein R, Strickland T. A review of the neuropsychological effects of commonly used prescription medications. Arch Clin Neuropsychol 1998; 13:259-84.
15. Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: Guidelines for management. J Psychiatry Neurosci 2000; 25:459-68.
16. Stokes A, Banich M, Elledge V. Testing the tests: an empirical evaluation of screening tests for the detection of cognitive impairment in aviators. Aviat Space Environ Med 1991; 2(8):783-8.